Cancer Research Technology Ltd.: Biopharma's Gateway to Cancer-Focused Academic Research

Cancer Research Technology - the technology transfer arm of Cancer Research UK, the world's largest charity - has long moved beyond simply commercializing and managing the IP generated by the half billion in research funding provided by Cancer Research UK to five core research institutes across the UK, as well as to researchers at dozens of other universities and organizations. CRT has a growing, 85-strong in-house drug discovery capability which is being expanded with the help of a five-year, £7 million ($11 million) grant from Cancer Research UK - and it's this that lured in AstraZeneca and another industry collaborator, Cephalon.